CYPRUMED GmbH, is an Austrian drug delivery company developing enabling technologies for the non-invasive delivery of biologics, with a focus on oral peptide delivery. Key activities include formulation research, IP protection and technology out-licensing.
Services:Development of oral formulations such as tablets and capsules. Enteric coating of tablets or capsules; In vitro enzymatic stability studies to investigate the stability of drugs in simulated or animal derived gastro-intestinal fluids.